Smart pill can track key biological markers in real-time
Coupling engineered bacteria with low-power electronics could be highly effective in diagnosis, treatment of bowel diseases.
Coupling engineered bacteria with low-power electronics could be highly effective in diagnosis, treatment of bowel diseases.
The Koch Institute’s Annual Symposium highlights emerging successes and challenges in the advancement of vaccines to prevent and treat cancer.
While developing targeted drug-delivery methods, the PhD student advocates for inclusion, belonging, and collaboration.
Award honors researchers who “have had a direct impact on business and industry through their scientific achievements and contributions.”
The printer generates vaccine-filled microneedle patches that can be stored long-term at room temperature and applied to the skin.
In a new study, immunostimulatory drugs slowed tumor growth without producing systemic inflammation.
Using ultrasonic waves that propel drug molecules into the skin, the patch could be used to treat a variety of skin conditions.
The global health care company Sanofi is providing $25 million to advance RNA research.
Researchers develop new, patient-friendly hydrogel platform for administering lifesaving biologics.
With further development, the programmable system could be used in a range of applications including gene and cancer therapies.
MIT Open Learning team awarded NIH grant to provide training in biomedical product development, entrepreneurship, and innovation.
A new computational framework could help researchers design granular hydrogels to repair or replace diseased tissues.
Companies founded by MechE faculty and alumni solve a variety of health care challenges, from better drug delivery to robotic surgery.
Using bottlebrush-shaped particles, researchers can identify and deliver synergistic combinations of cancer drugs.
Metal stents or staples that disintegrate on demand inside the body could eliminate some surgical and endoscopic procedures.